Elite in Stroke

Beom J. Kim

Gyeonggi-do, KR 
Elite in Stroke
Gyeonggi-do, KR 
OverviewLocationsClinical Research

Overview

Beom Kim practices in Gyeonggi-do, Republic of Korea. Kim is rated as an Elite expert by MediFind in the treatment of Stroke. Their top areas of expertise are Stroke, Autosomal Recessive Hypotrichosis, Transient Ischemic Attack (TIA), Thrombectomy, and Stent Placement.

Their clinical research consists of co-authoring 695 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 252 articles in the study of Stroke.

Locations

Gyeonggi-do, Republic of Korea
Other Locations
Seoul, Republic of Korea
Songnam, Republic of Korea
Gwangmyeong, Republic of Korea
Daegu, Republic of Korea
Suwon, Republic of Korea
Seongnam-si, Republic of Korea
Pohang, Republic of Korea
Wondu, Republic of Korea
Chinju, Republic of Korea
Gwangju, Republic of Korea
Anseong, Republic of Korea
Daejeon, 305340, Republic of Korea
Goyang, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2/Phase 3
A Randomized, Subject & Evaluator-blind, Matched Pairs, Prospective Study to Compare the Safety and Efficacy Between SYB Filler (SF-01) and Ellansé M in the Correction of Nasolabial Folds
A Randomized, Subject & Evaluator-blind, Matched Pairs, Prospective Study to Compare the Safety and Efficacy Between SYB Filler (SF-01) and Ellansé M in the Correction of Nasolabial Folds
Enrollment Status: Completed
Publish Date: November 22, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

694 Total Publications

Differential Effects of Admission Hemoglobin A1c by Estimated Glomerular Filtration Rate Stages on Mortality in Acute Ischemic Stroke and Diabetes.
Differential Effects of Admission Hemoglobin A1c by Estimated Glomerular Filtration Rate Stages on Mortality in Acute Ischemic Stroke and Diabetes.
Journal: Journal of the American Heart Association
Published: December 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kim's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 59 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile